Growth Hormone Peptides
Secretagogues that stimulate your body's natural growth hormone production
Quick Answer
Growth hormone secretagogues stimulate your pituitary gland to release more GH naturally, rather than injecting synthetic HGH directly. Common options include CJC-1295 (long-acting GHRH analog), ipamorelin (selective GH releaser), sermorelin (29-amino acid GHRH fragment), and tesamorelin (FDA-approved for HIV lipodystrophy). Research shows 2-10x increases in GH and 1.5-3x increases in IGF-1. They're safer than direct HGH because negative feedback prevents overdose. However, most uses are off-label, and they require medical supervision due to effects on glucose and potential cancer considerations.
Medium Evidence
Good studies, but more research needed
Safety: GH peptides require medical supervision due to effects on glucose, IGF-1, and potential tumor risks. Tesamorelin is FDA-approved for HIV lipodystrophy; others are off-label.
What Is This?
Growth hormone peptides, also called GH secretagogues, are compounds that stimulate your pituitary gland to produce and release more growth hormone naturally. Unlike direct HGH injection, they work with your body's feedback systems.
Main categories:
GHRH Analogs (mimic growth hormone-releasing hormone):
- CJC-1295: Long-acting (5-8 day half-life), sustained GH elevation
- CJC-1295 without DAC (Mod GRF 1-29): Shorter-acting, mimics natural pulsatile release
- Sermorelin: 29-amino acid fragment, shortest synthetic peptide with full GHRH activity
- Tesamorelin: 44-amino acid, FDA-approved for HIV lipodystrophy
- Ipamorelin: Highly selective, doesn't affect cortisol/prolactin
- GHRP-2 & GHRP-6: Older compounds, less selective, increase appetite
How It Works
GH secretagogues work through two complementary pathways:
GHRH Pathway (CJC-1295, Sermorelin, Tesamorelin): These peptides bind to GHRH receptors on pituitary somatotroph cells, triggering growth hormone synthesis and release. CJC-1295 with DAC has extended half-life (5-8 days) due to albumin binding, maintaining elevated GH for days after a single injection.
Ghrelin/GHSR Pathway (Ipamorelin, GHRPs): These bind to growth hormone secretagogue receptors (GHS-R1a), the same receptors that respond to ghrelin. Ipamorelin is highly selective, it releases GH without affecting cortisol, prolactin, or aldosterone, unlike older GHRPs.
Synergistic Combination: CJC-1295 + ipamorelin is popular because they work through different mechanisms. Ipamorelin causes a sharp GH spike, while CJC-1295 provides sustained elevation. Together, they produce both enhanced peaks and higher baseline levels.
Research evidence:
- CJC-1295 single injection: 2-10x GH increase for 6+ days, 1.5-3x IGF-1 increase for 9-11 days
- Tesamorelin: Reduces trunk fat by 18% in HIV patients, increases lean body mass
- Sermorelin: Effective in treating GH deficiency in children
How to Start
Get medical evaluation first
GH peptides require medical supervision. Get baseline bloodwork including IGF-1, fasting glucose, HbA1c, and a comprehensive metabolic panel. Discuss your goals and rule out contraindications.
Tips:
- •Work with a physician experienced in peptide therapy
- •Rule out active cancer, pituitary issues, or uncontrolled diabetes
- •Document baseline IGF-1 to monitor therapy
Choose the appropriate peptide(s)
Selection depends on your goals and risk tolerance. Tesamorelin is the only FDA-approved option (for HIV lipodystrophy). CJC-1295 + ipamorelin is popular for general anti-aging. Sermorelin mimics natural pulsatile release.
Tips:
- •Tesamorelin: Most data, FDA-approved (off-label for non-HIV)
- •CJC-1295 + Ipamorelin: Popular combination, strong GH elevation
- •Sermorelin: Shorter-acting, may be gentler
Learn injection technique
GH peptides are administered via subcutaneous injection, typically in the abdomen. Proper reconstitution with bacteriostatic water and sterile technique are essential.
Tips:
- •Inject 30-60 minutes before bed on empty stomach
- •Rotate injection sites to prevent lipodystrophy
- •Store reconstituted peptides refrigerated
Follow appropriate dosing schedule
Dosing varies by peptide. Most are administered once daily, ideally before bed when natural GH release peaks. Some protocols use 5 days on, 2 days off to prevent desensitization.
Tips:
- •Tesamorelin: 2mg daily subcutaneous
- •Ipamorelin: 100-300mcg before bed
- •CJC-1295 no DAC: 100-300mcg combined with ipamorelin
Monitor and adjust
Regular bloodwork is essential. Monitor IGF-1 (should increase but stay within range), glucose metabolism, and watch for side effects. Adjust dosing based on response.
Tips:
- •Recheck IGF-1 at 4-6 weeks
- •Monitor fasting glucose if diabetic/pre-diabetic
- •Watch for water retention, joint pain, or numbness
What to Expect
Initial administration
Learning injection technique and establishing routine. May notice improved sleep quality relatively quickly. Some experience mild water retention or injection site reactions.
Early changes
Sleep quality improvements often reported first. May notice better recovery from exercise, improved skin quality, subtle changes in body composition. IGF-1 levels should be rising.
Body composition changes
Gradual reduction in body fat (especially visceral fat with tesamorelin) and potential increase in lean mass. Effects are more subtle than direct HGH. Continued improvement in recovery and sleep.
Full effects
Maximum benefits typically seen after 3-6 months of consistent use. Body composition, skin quality, energy, and recovery at peak improvement. Long-term users often cycle or maintain indefinitely.
Dosing Information
Recommended Dose
Varies by peptide, see notes
Range
Ipamorelin: 100-300mcg; CJC-1295: 100-300mcg; Tesamorelin: 2mg
- •Tesamorelin: 2mg once daily subcutaneous (FDA dosing)
- •Ipamorelin: 100-300mcg once daily, typically before bed
- •CJC-1295 without DAC: 100-300mcg combined with ipamorelin
- •CJC-1295 with DAC: 2mg once or twice weekly (long half-life)
- •Sermorelin: 100-500mcg before bed
- •Most protocols suggest 5 days on, 2 days off to prevent desensitization
These peptides require medical supervision. Monitor IGF-1 and glucose levels regularly. Not approved for anti-aging or performance enhancement.
Practical Details
Timing
Inject 30-60 minutes before bed on an empty stomach (no food for 2-3 hours prior). This timing aligns with natural GH release patterns and maximizes the pulse.
Duration
Typical cycles run 3-6 months. Some users cycle (3 months on, 1 month off); others use continuously with medical monitoring. Long-term effects need more study.
Cost
$150-400/month depending on peptide and source
Tesamorelin is most expensive ($300-500/month) but FDA-approved. Compounded ipamorelin/CJC-1295 typically $150-250/month. Research-grade peptides cheaper but quality varies.
Risks & Considerations
Potential Risks
- •Potential to stimulate growth of existing tumors (theoretical)
- •Glucose intolerance and potential diabetes risk
- •Water retention and joint pain
- •CJC-1295 phase II trials discontinued after subject death (likely unrelated)
- •Off-label use for most indications
- •Long-term effects in healthy adults not well-studied
- •Product quality varies in unregulated market
Possible Side Effects
- •Injection site reactions (redness, itching, pain)
- •Water retention and bloating
- •Joint pain or stiffness
- •Numbness or tingling (carpal tunnel-like)
- •Increased appetite (especially with GHRPs)
- •Headache
- •Flushing (especially with sermorelin)
Who Should Avoid This
- •Active cancer or history of cancer
- •Pituitary tumors or abnormalities
- •Previous radiation therapy to head/brain
- •Uncontrolled diabetes
- •Pregnancy or breastfeeding
- •Severe kidney or liver disease
- •History of hypersensitivity to GHRH or analogs
Key Research
CJC-1295 prolonged GH stimulation in healthy adults
Journal of Clinical Endocrinology & Metabolism, 2006
Single CJC-1295 injection increased GH 2-10 fold for 6+ days and IGF-1 1.5-3 fold for 9-11 days in healthy adults. Half-life was 5.8-8.1 days. No serious adverse reactions reported.
View StudySermorelin for adult GH insufficiency
Clinical Interventions in Aging, 2008
Review concluded sermorelin offers physiological advantages over direct HGH: natural feedback prevents overdose, preserves pituitary function, and may have fewer side effects long-term.
View StudyTesamorelin long-term safety in HIV lipodystrophy
AIDS, 2008
Tesamorelin was well-tolerated over 52 weeks. Changes in glucose parameters were not clinically significant. Reduced trunk fat, increased IGF-1 levels maintained throughout.
View StudyThe GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats
Journal of Endocrinology, 2000
12-week treatment with ipamorelin increased bone mineral content in adult female rats, with increased bone dimensions. Effects mediated through GH release pathway.
View StudyFrequently Asked Questions
Are GH peptides safer than HGH?
In some ways, yes. GH secretagogues work with your body's feedback systems, somatostatin prevents GH levels from getting too high, unlike direct HGH injection where overdose is easy. However, they're not risk-free: they can still affect glucose metabolism, potentially stimulate tumors, and lack long-term safety data in healthy adults. "Safer" doesn't mean "safe" without supervision.
Which peptide combination is best?
CJC-1295 (without DAC) + ipamorelin is the most popular combination. They work through different pathways: CJC-1295 provides sustained GH elevation while ipamorelin creates sharp peaks. Together they produce both enhanced peaks and higher baseline GH. For FDA-approved options, tesamorelin has the most data but is only approved for HIV lipodystrophy.
Do I need to cycle GH peptides?
Many protocols suggest cycling (e.g., 5 days on/2 days off, or 3 months on/1 month off) to prevent receptor desensitization. However, evidence for this is largely anecdotal. CJC-1295 with DAC has a long half-life, so it's typically dosed once or twice weekly rather than daily. Work with your physician to determine the best approach.
Will GH peptides show up on drug tests?
WADA has banned many GH secretagogues, and detection methods exist for competitive testing. CJC-1295, ipamorelin, and GHRPs are prohibited in-competition and out-of-competition for athletes. Even tesamorelin, despite being FDA-approved, would likely violate anti-doping rules for its GH-elevating effects.
Can GH peptides cause cancer?
This is a theoretical concern, not proven. IGF-1 (which increases with GH peptide use) can promote cell proliferation, and elevated IGF-1 is associated with some cancers epidemiologically. There's no evidence GH peptides cause cancer, but they're contraindicated in anyone with active cancer or cancer history because they could theoretically promote tumor growth.
Why inject before bed?
Natural GH release peaks during deep sleep, particularly in the first few hours after falling asleep. Injecting 30-60 minutes before bed, on an empty stomach, aligns with and amplifies this natural pulse. Food, especially carbohydrates, can blunt GH release, so fasting for 2-3 hours before injection is recommended.
Sources
Related Interventions
Disclaimer: This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider before starting any new health practice or supplement. Evidence levels and recommendations can change, this content was last updated December 2025.